Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer

The aim of the present study was to retrospectively evaluate the feasibility of cisplatin/pemetrexed/bevacizumab (CPB) therapy at a bevacizumab (BEV) dose of 15 mg/kg as a first-line chemotherapeutic strategy for patients with advanced non-squamous non-small cell lung cancer (NSCLC). A total of 31 c...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Lett
Main Authors: HIRAI, FUMIHIKO, SETO, TAKASHI, INAMASU, EIKO, SHIMOKAWA, MOTOTSUGU, TOYOKAWA, GOUJI, YOSHIDA, TSUKIHISA, NOSAKI, KANAME, TAKENAKA, TOMOYOSHI, YAMAGUCHI, MASAFUMI, TAKENOYAMA, MITSUHIRO, ICHINOSE, YUKITO
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2015
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4473666/
https://ncbi.nlm.nih.gov/pubmed/26137109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3086
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items